Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9575930rdf:typepubmed:Citationlld:pubmed
pubmed-article:9575930lifeskim:mentionsumls-concept:C0232338lld:lifeskim
pubmed-article:9575930lifeskim:mentionsumls-concept:C0064830lld:lifeskim
pubmed-article:9575930lifeskim:mentionsumls-concept:C0083536lld:lifeskim
pubmed-article:9575930lifeskim:mentionsumls-concept:C0205276lld:lifeskim
pubmed-article:9575930lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:9575930lifeskim:mentionsumls-concept:C1154393lld:lifeskim
pubmed-article:9575930lifeskim:mentionsumls-concept:C0547047lld:lifeskim
pubmed-article:9575930pubmed:issue4 Pt 2lld:pubmed
pubmed-article:9575930pubmed:dateCreated1998-6-2lld:pubmed
pubmed-article:9575930pubmed:abstractTextLocal inhibition of nitric oxide (NO) synthesis with L-arginine analogs such as NG-nitro-L-arginine methyl ester (L-NAME) decreased red blood cell velocity (VRBC) in capillaries and increased leukocyte adhesion in postcapillary venules in rat skeletal muscle. The goal of the present study was to determine the mechanism of this response to L-NAME. Using intravital videomicroscopy, we examined blood flow in the surface microvasculature of rat extensor digitorum longus muscle. L-NAME (30 mM in the pipette) locally applied to capillaries (300 microns from feeding arteriole) reduced VRBC [control VRBC = 244 +/- 53 (SE) microns/s; delta VRBC = -52 +/- 8%] and increased leukocyte adhesion (from 0.2 +/- 0.01 to 1.3 +/- 0.3 cells/100 microns) in control animals. Systemic pretreatment with fucoidan (selectin binder), superoxide dismutase and catalase (extracellular antioxidants), dimethylthiourea (intracellular antioxidant), or ketotifen (mast cell stabilizer) did not alter this response. Pretreatment with CL26, an anti-CD18 antibody, abolished the L-NAME response. Our results suggest that L-NAME increased leukocyte-endothelial interactions via an effect on CD11/CD18 or its ligand, intercellular adhesion molecule.lld:pubmed
pubmed-article:9575930pubmed:languageenglld:pubmed
pubmed-article:9575930pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9575930pubmed:citationSubsetIMlld:pubmed
pubmed-article:9575930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9575930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9575930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9575930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9575930pubmed:statusMEDLINElld:pubmed
pubmed-article:9575930pubmed:monthAprlld:pubmed
pubmed-article:9575930pubmed:issn0002-9513lld:pubmed
pubmed-article:9575930pubmed:authorpubmed-author:MitchellD JDJlld:pubmed
pubmed-article:9575930pubmed:authorpubmed-author:YuJJlld:pubmed
pubmed-article:9575930pubmed:authorpubmed-author:TymlKKlld:pubmed
pubmed-article:9575930pubmed:issnTypePrintlld:pubmed
pubmed-article:9575930pubmed:volume274lld:pubmed
pubmed-article:9575930pubmed:ownerNLMlld:pubmed
pubmed-article:9575930pubmed:authorsCompleteYlld:pubmed
pubmed-article:9575930pubmed:paginationH1264-8lld:pubmed
pubmed-article:9575930pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:meshHeadingpubmed-meshheading:9575930-...lld:pubmed
pubmed-article:9575930pubmed:year1998lld:pubmed
pubmed-article:9575930pubmed:articleTitleLocal L-NAME decreases blood flow and increases leukocyte adhesion via CD18.lld:pubmed
pubmed-article:9575930pubmed:affiliationDepartment of Pharmacology and Toxicology, University of Western Ontario, London, Canada.lld:pubmed
pubmed-article:9575930pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9575930pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9575930lld:pubmed